NSG
RMD icon

Nalls Sherbakoff Group’s ResMed RMD Stock Holding History

Nalls Sherbakoff Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$2.41K Hold
14
– – ﹤0.01% 346
2023
Q3 		$2.07K Hold
14
– – ﹤0.01% 346
2023
Q2 		$2.95K Hold
14
– – ﹤0.01% 340
2023
Q1 		$3.02K Buy
+14
New +$3.04K ﹤0.01% 348

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nalls Sherbakoff Group's RMD Position: Q4 2023 in Review

Nalls Sherbakoff Group held its ResMed (RMD) position steady in Q4 2023 at 14 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Nalls Sherbakoff Group first reported a position in RMD in Q1 2023 and has held it in 4 quarters since. The position peaked at $3.02K in Q1 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

  • Nalls Sherbakoff Group held 14 shares of ResMed worth $2.41K as of Q4 2023.
  • Nalls Sherbakoff Group left its ResMed share count unchanged in Q4 2023.
  • ResMed made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q4 2023, its #346 holding.
  • Nalls Sherbakoff Group first reported a position in ResMed in Q1 2023 and has held it in 4 quarters since.
  • Nalls Sherbakoff Group's ResMed position peaked at $3.02K in Q1 2023.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Nalls Sherbakoff Group's 13F filing for Q4 2023, filed 9 Apr 2024.